Synaptic Resilience: A New Hope
Summary A new drug candidate, LM11A-31, targeting synaptic resilience has shown promising results in a recent Alzheimer’s disease clinical trial. The drug was well-tolerated by participants and showed potential in mitigating brain damage. This breakthrough […]
